tiprankstipranks

Reshma Kewalramani Insider Profile

18 Followers
Reshma Kewalramani, CEO & President, Director at Vertex Pharmaceuticals, holds 75.77K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 186.00K shares in Ginkgo Bioworks Holdings (Ticker: DNA).
tipranks
Reshma Kewalramani

Reshma Kewalramani
Vertex Pharmaceuticals (VRTX)
CEO & President, Director

Not Ranked
Reshma Kewalramani has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$36M
95.85%
4.15%
A breakdown of Reshma Kewalramani's holdings

Insider Roles

Vertex Pharmaceuticals
(VRTX)
CEO & President, Director
Ginkgo Bioworks Holdings
(DNA)
Director
Roles that Reshma Kewalramani holds in companies

Most Profitable Insider Trade

Stock:
Vertex Pharmaceuticals
(VRTX)
Rating:Informative Buy
Date:Aug 23, 2021 - Aug 23, 2022
Return:+44.20%
The most profitable trade made by Reshma Kewalramani

Reshma Kewalramani's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vertex Pharmaceuticals
Nov 12, 2024
CEO & President, Director
Uninformative Sell
7.83M
$34.98M
Ginkgo Bioworks Holdings
Jun 14, 2024
Director
Uninformative Buy
53.37K
$1.51M
List of latest transactions for each holding click on a transaction to see Reshma Kewalramani's performance on stock

Reshma Kewalramani insider profile FAQ

What is the percentage of profitable transactions made by Reshma Kewalramani?
The percentage of profitable transactions made by Reshma Kewalramani is ―.
    What is the average return per transaction made by Reshma Kewalramani?
    The average return per transaction made by Reshma Kewalramani is ―.
      What stocks does Reshma Kewalramani hold?
      Reshma Kewalramani holds: VRTX, DNA stocks.
        What was Reshma Kewalramani’s latest transaction?
        Reshma Kewalramani latest transaction was an Uninformative Sell of $7.83M.
          What was Reshma Kewalramani's most profitable transaction?
          Reshma Kewalramani’s most profitable transaction was an Informative Buy of VRTX stock on August 23, 2021. The return on the trade was 44.20%.
            What is Reshma Kewalramani's role in Vertex Pharmaceuticals?
            Reshma Kewalramani's role in Vertex Pharmaceuticals is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.